Cargando…

Intralymphatic histiocytosis in a patient with lung adenocarcinoma treated with pembrolizumab: a case report

BACKGROUND: Pembrolizumab, an anti-programmed cell death-1 protein monoclonal antibody, is effective for patients with advanced non-small-cell lung cancer. However, immune checkpoint inhibitors such as pembrolizumab induce various immune-related adverse events, involving the lung, liver, gastrointes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sugano, Teppei, Seike, Masahiro, Funasaka, Yoko, Yoshida, Mai, Takayama, Ryoko, Okamura, Ken, Nakanishi, Asuka, Tanaka, Toru, Takeuchi, Susumu, Noro, Rintaro, Minegishi, Yuji, Kubota, Kaoru, Saeki, Hidehisa, Gemma, Akihiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391791/ https://www.ncbi.nlm.nih.gov/pubmed/30813943 http://dx.doi.org/10.1186/s40425-019-0534-z

Ejemplares similares

Intralymphatic Histiocytosis with Massive Interstitial Granulomatous Foci in a Patient with Rheumatoid Arthritis
por: Tanaka, Mayuri, et al.
Publicado: (2017)

A case of interstitial lung disease with alveolar hemorrhage induced by pembrolizumab
por: Sugano, Teppei, et al.
Publicado: (2018)

Intralymphatic Histiocytosis
por: Garcia-Mouronte, Emilio, et al.
Publicado: (2022)

Pembrolizumab-induced agranulocytosis in a pulmonary pleomorphic carcinoma patient who developed interstitial lung disease and ocular myasthenia gravis
por: Tozuka, Takehiro, et al.
Publicado: (2018)

Intralymphatic Histiocytosis: An Unusual Presentation
por: Blackwell, Timothy J., et al.
Publicado: (2021)

Pembrolizumab and salvage chemotherapy in EGFR T790M-positive non-small-cell lung cancer with high PD-L1 expression
por: Tozuka, Takehiro, et al.
Publicado: (2018)

Control of the MYC-eIF4E axis plus mTOR inhibitor treatment in small cell lung cancer
por: Matsumoto, Masaru, et al.
Publicado: (2015)

Intralymphatic Histiocytosis Associated with Osteoarthritis: A Case Report
por: Koo, Taehan, et al.
Publicado: (2022)

Immune checkpoint inhibitor‐associated interstitial lung diseases correlate with better prognosis in patients with advanced non‐small‐cell lung cancer
por: Sugano, Teppei, et al.
Publicado: (2020)

Carboplatin plus nanoparticle albumin-bound paclitaxel for the treatment of thymic carcinoma
por: Takahashi, Akiko, et al.
Publicado: (2022)

miR-200/ZEB axis regulates sensitivity to nintedanib in non-small cell lung cancer cells
por: NISHIJIMA, NOBUHIKO, et al.
Publicado: (2016)

Successful Treatment with Afatinib after Osimertinib-induced Interstitial Lung Disease in a Patient with EGFR-mutant Non-small-cell Lung Cancer
por: Nishima, Shunichi, et al.
Publicado: (2020)

Intralymphatic histiocytosis of the upper eyelid in a patient of Korean descent: A case report
por: Ha, Dong Hee, et al.
Publicado: (2023)

MET FISH-positive status predicts short progression-free survival and overall survival after gefitinib treatment in lung adenocarcinoma with EGFR mutation
por: Noro, Rintaro, et al.
Publicado: (2015)

Ankyrin Repeat Domain 1 Overexpression is Associated with Common Resistance to Afatinib and Osimertinib in EGFR-mutant Lung Cancer
por: Takahashi, Akiko, et al.
Publicado: (2018)

Osimertinib early dose reduction as a risk to brain metastasis control in EGFR‐mutant non‐small cell lung cancer
por: Tozuka, Takehiro, et al.
Publicado: (2023)

Exosome‐derived miR‐210 involved in resistance to osimertinib and epithelial–mesenchymal transition in EGFR mutant non‐small cell lung cancer cells
por: Hisakane, Kakeru, et al.
Publicado: (2021)

Intralymphatic immunotherapy
por: Senti, Gabriela, et al.
Publicado: (2015)

Successful Treatment with Short-Term Steroid Against Severe Hepatitis Confirmed by Liver Biopsy in a Patient with Advanced Squamous-Cell Lung Cancer Receiving a Combination of Pembrolizumab, Carboplatin, and Nab-Paclitaxel: A Case Report
por: Hayashi, Anna, et al.
Publicado: (2022)

Effective Crizotinib schedule for an elderly patient with ALK rearranged non-small-cell lung cancer: a case report
por: Fukuizumi, Aya, et al.
Publicado: (2015)

Efficacy with Trastuzumab Deruxtecan for Non-Small-Cell Lung Cancer Harboring HER2 Exon 20 Insertion Mutation in a Patient with a Poor Performance Status: A Case Report
por: Kato, Yuki, et al.
Publicado: (2021)

Long Non-Coding RNA CRNDE Is Involved in Resistance to EGFR Tyrosine Kinase Inhibitor in EGFR-Mutant Lung Cancer via eIF4A3/MUC1/EGFR Signaling
por: Takahashi, Satoshi, et al.
Publicado: (2021)

Acute respiratory failure due to Aspergillus niger infection with acute fibrinous and organazing pneumonia: A case report
por: Okamura, Ken, et al.
Publicado: (2022)

Dietary Fiber Inulin Improves Murine Imiquimod-Induced Psoriasis-like Dermatitis
por: Yoshida, Mai, et al.
Publicado: (2023)

The respiratory microbiome associated with chronic obstructive pulmonary disease comorbidity in non‐small cell lung cancer
por: Shimizu, Masamitsu, et al.
Publicado: (2022)

Standard versus low‐dose nab‐paclitaxel in previously treated patients with advanced non‐small cell lung cancer: A randomized phase II trial (JMTO LC14‐01)
por: Takeuchi, Susumu, et al.
Publicado: (2023)

Melasma in a Male Patient due to Estrogen Therapy for Prostate Cancer
por: Ogita, Azusa, et al.
Publicado: (2015)

The Transplantability of Tumours by Intravenous and Intralymphatic Routes
por: Wallace, A. C., et al.
Publicado: (1965)

Papillary intralymphatic angioendothelioma: Dabska tumor()()
por: Silva, Thadeu Santos, et al.
Publicado: (2020)

The disposition of cytotoxic agents after intralymphatic infusion.
por: Calnan, J. S., et al.
Publicado: (1967)

Papillary intralymphatic angioendothelioma: An extremely rare tumor
por: Kaplan, Güven Ozan, et al.
Publicado: (2021)

MiR-23a regulates TGF-β-induced epithelial-mesenchymal transition by targeting E-cadherin in lung cancer cells
por: CAO, MENGRU, et al.
Publicado: (2012)

Anticancer drug clustering in lung cancer based on gene expression profiles and sensitivity database
por: Gemma, Akihiko, et al.
Publicado: (2006)

Prognostic significance of PIK3CA and SOX2 in Asian patients with lung squamous cell carcinoma
por: IIJIMA, YOSHIHITO, et al.
Publicado: (2014)

Platelet-Rich Plasma Injection and Cutaneous Sarcoidal Granulomas
por: Serizawa, Naotaka, et al.
Publicado: (2017)

Overcoming drug-tolerant cancer cell subpopulations showing AXL activation and epithelial–mesenchymal transition is critical in conquering ALK-positive lung cancer
por: Nakamichi, Shinji, et al.
Publicado: (2018)

Allergen-specific intralymphatic immunotherapy in human and animal studies
por: Kim, Seon Tae, et al.
Publicado: (2017)

A Case of Binocular Metastatic Choroidal Tumor Originating from Pulmonary Adenocarcinoma Successfully Treated with Molecular Target Therapy
por: Yamaoka, Masataka, et al.
Publicado: (2023)

Benefits from Adjuvant Chemotherapy in Patients with Resected Non-Small Cell Lung Cancer: Possibility of Stratification by Gene Amplification of ACTN4 According to Evaluation of Metastatic Ability
por: Tozuka, Takehiro, et al.
Publicado: (2022)

Gefitinib (IRESSA) sensitive lung cancer cell lines show phosphorylation of Akt without ligand stimulation
por: Noro, Rintaro, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_kt0n37mur2cv0umggv0koshofs